Subscribe To
Dufry expands by more than 30% in spain, despite losing airports
The world's biggest travel retailer is bringing hybrid retail and F&B concepts to Spain for the first time....
July 29, 2023, 11:56 pm
Eur/usd weekly outlook
EUR/USD’s fall from 1.1274 short term top extended last week and hit as low as 1.0942. Further fall is expected this week as long as 1.1148 resistan...
July 29, 2023, 9:41 am
Gbp/usd weekly outlook
GBP/USD’s decline from 1.3141 continued last week despite interim recovery. Further decline is in favor this week. Break of 1.2761 will target 55 D ...
July 29, 2023, 9:30 am
Usd/chf weekly outlook
USD/CHF dropped to 0.8851 last week but quickly recovered since then. Initial bias is mildly on the upside this week for 0.8818 support turned resista...
July 29, 2023, 9:25 am
Gbp/jpy weekly outlook
GBP/JPY dropped sharply to as low as 176.29 but rebounded strong well ahead of 38.2% retracement of 155.33 to 183.99 at 173.04. The development argues...
July 29, 2023, 9:04 am
Voluntary carbon market finalizes framework for credits
The new framework to better define high-quality carbon credits for market participants and buyers was finalized July 27. The hope is that it will inst...
July 28, 2023, 4:49 pm
Mikmak ceo on meta seizing momentum with threads
MikMak CEO Rachel Tipograph and Bloomberg's Alex Barinka discuss the rise of the "everything" app and how Threads could help ...
July 28, 2023, 3:32 pm
Li stock alert: why li auto is revving up 9% today
Shares of Li Auto (NASDAQ: LI ) stock are revving up today by about 9%, bringing the Chinese electric vehicle (EV) company's year-to-date (YTD) return...
July 28, 2023, 2:49 pm
Event tech trends to watch for in 2023
Innovation is continually redefining the way we organize, host, and experience events in the ever-changing realm of event technology. Event tech conti...
July 28, 2023, 2:22 pm
When art meets philanthropy: gofundme campaigns supporting creative projects
Passion and vision are often fuels for the drive to bring ambitious projects to reality in the realm of...
July 28, 2023, 12:51 pm
Fate therapeutics to webcast conference call reporting second quarter 2023 financial results
SAN DIEGO, July 28, 2023 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage ...
July 28, 2023, 12:00 pm
Gold price struggling around $1,950 before us pce data
The bias remains bearish in the short term. A new lower low activates more declines. The US economic figures and the Canadian GDP should ...
July 28, 2023, 9:59 am
Ecb's villeroy: upcoming meeting decisions will be entirely data driven
Need to be pragmatic and keep an open mindPerseverance is now key given the time needed for full transmission of policyFrench inflation is falling eve...
July 28, 2023, 9:52 am
Why is enphase energy (enph) down 11% today?
Enphase Energy (NASDAQ: ENPH ) stock is falling on Friday following the release of its earnings report for the second quarter of 2023. That report sa...
July 28, 2023, 9:35 am
Moneyexpo india 2023: bringing leading forex and stock companies
MoneyExpo India 2023, the premier finance event of the year, is delighted to announce the participation of an impressive lineup of both forex and stoc...
July 28, 2023, 7:56 am
Chain reaction: blackrock and the sec’s bitcoin showdown
Once the pariah of the financial world, Bitcoin’s staying power has won over Wall Street. Asset managers are now racing to ...
July 28, 2023, 3:59 am
Gbp/usd daily outlook
Daily Pivots: (S1) 1.2720; (P) 1.2858; (R1) 1.2934; More… GBP/USD’s fall from 1.3141 resumed by breaking 1.2796 support. Intraday bias is back on ...
July 28, 2023, 3:21 am
Usd/chf daily outlook
Daily Pivots: (S1) 0.8598; (P) 0.8648; (R1) 0.8744; More…. Intraday bias in USD/CHF remains neutral for the moment. On the upside, break of 0.8699 w...
July 28, 2023, 3:19 am
Eur/aud daily outlook
Daily Pivots: (S1) 1.6292; (P) 1.6351; (R1) 1.6422; More… Sideway trading continues in EUR/AUD and intraday bias remains neutral at this point. With...
July 28, 2023, 3:08 am
Astrazeneca unit strikes $1bn rare diseases deal with pfizer
AstraZeneca PLC's rare disease unit, Alexion, has unveiled a $1 billion agreement to acquire Pfizer's early-stage gene therapy portfolio, a strategic...
July 28, 2023, 2:41 am